Showing results (1-10 of 829) with videos related to
Sort By:
Pageof 83
British Journal of Clinical Pharmacology|January 3, 2013
Direct renin inhibition in chronic kidney diseaseFrederik Persson, Peter Rossing, Hans-Henrik ParvingDiabetes Research and Clinical Practice|December 4, 2014
Microalbuminuria: a parameter that has changed diabetes careHans-Henrik Parving, Frederik Persson, Peter RossingJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 5, 2016
Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic reviewFrederik Persson, Morten Lindhardt, Peter Rossing, et al.Journal of Diabetes and Its Complications|August 1, 2016
Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetesFrederik Persson, Simone Theilade, Jesper Eugen-Olsen, et al.Kidney International|February 12, 2017
Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefitsJens Oellgaard, Peter Gæde, Peter Rossing, et al.Journal of Diabetes and Its Complications|October 5, 2018
Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuriaJens Oellgaard, Peter Gæde, Frederik Persson, et al.Nature Reviews. Nephrology|December 10, 2014
Diabetic nephropathy in 2014: improved cardiorenal prognosis in diabetic nephropathyHans-Henrik Parving, Peter RossingDiabetes Research and Clinical Practice|January 3, 2012
High YKL-40 levels predict mortality in patients with type 2 diabetesFrederik Persson, Camilla Noelle Rathcke, Mari-Anne Gall, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 21, 2012
Impact of glycaemic control on the effect of direct renin inhibition in the AVOID studyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.Kidney International|July 18, 2017
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathyJulie Galsgaard, Frederik Persson, Tine Willum Hansen, et al.Pageof 83